Total Payments
$782,771
2024 Payments
$100,292
Companies
68
Transactions
1,497
Medicare Patients
3,189
Medicare Billing
$378,425
Payment Breakdown by Category
Other$544,219 (69.5%)
Travel$147,708 (18.9%)
Consulting$61,406 (7.8%)
Food & Beverage$28,844 (3.7%)
Education$593.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $533,219 | 220 | 68.1% |
| Travel and Lodging | $147,708 | 387 | 18.9% |
| Consulting Fee | $61,406 | 27 | 7.8% |
| Food and Beverage | $28,844 | 852 | 3.7% |
| Honoraria | $9,500 | 3 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,500 | 1 | 0.2% |
| Education | $593.93 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $535,087 | 703 | $0 (2024) |
| Merck Sharp & Dohme LLC | $143,242 | 180 | $0 (2023) |
| Axsome Therapeutics, Inc. | $35,021 | 44 | $0 (2024) |
| Eisai Inc. | $33,096 | 47 | $0 (2023) |
| Avadel CNS Pharmaceuticals, LLC | $13,645 | 30 | $0 (2024) |
| Amgen Inc. | $8,470 | 21 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $4,037 | 52 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $1,755 | 3 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $1,424 | 48 | $0 (2024) |
| UCB, Inc. | $726.96 | 42 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100,292 | 194 | JAZZ PHARMACEUTICALS INC. ($78,715) |
| 2023 | $120,134 | 222 | JAZZ PHARMACEUTICALS INC. ($84,768) |
| 2022 | $92,047 | 202 | JAZZ PHARMACEUTICALS INC. ($86,463) |
| 2021 | $120,285 | 173 | JAZZ PHARMACEUTICALS INC. ($101,053) |
| 2020 | $60,391 | 108 | Jazz Pharmaceuticals Inc. ($48,991) |
| 2019 | $94,772 | 198 | JAZZ PHARMACEUTICALS INC. ($91,152) |
| 2018 | $95,171 | 218 | Merck Sharp & Dohme Corporation ($49,979) |
| 2017 | $99,679 | 182 | Merck Sharp & Dohme Corporation ($90,681) |
All Payment Transactions
1,497 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: NEUROLOGY | ||||||
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Travel and Lodging | In-kind items and services | $1,328.57 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $33.96 | General |
| Category: Narcoplepsy | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $134.98 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: Neurology | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Narcoplepsy | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $34.01 | General |
| Category: Narcoplepsy | ||||||
| 11/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Neurology | ||||||
| 11/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Parkinson's Disease | ||||||
| 11/08/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Neurology | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 806 | 961 | $327,142 | $91,825 |
| 2022 | 13 | 808 | 983 | $306,735 | $90,152 |
| 2021 | 13 | 824 | 1,023 | $310,409 | $103,255 |
| 2020 | 13 | 751 | 869 | $273,901 | $93,194 |
Total Patients
3,189
Total Services
3,836
Medicare Billing
$378,425
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 202 | 287 | $78,925 | $20,967 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 96 | $47,136 | $13,297 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 128 | $33,940 | $11,633 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 45 | $13,614 | $6,510 | 47.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 16 | 16 | $22,720 | $5,905 | 26.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 51 | 80 | $25,976 | $4,942 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 47 | 47 | $16,450 | $4,924 | 29.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 47 | 47 | $20,915 | $4,411 | 21.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $10,372 | $4,407 | 42.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 28 | 28 | $11,889 | $3,916 | 32.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 27 | 27 | $12,825 | $2,682 | 20.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 55 | 56 | $8,944 | $2,556 | 28.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 11 | 13 | $4,945 | $2,177 | 44.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 15 | $4,095 | $1,464 | 35.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 29 | 29 | $10,788 | $1,027 | 9.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 22 | 22 | $3,608 | $1,004 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 200 | 287 | $69,905 | $21,385 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 130 | $34,490 | $10,970 | 31.8% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 63 | 108 | $37,984 | $8,365 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 70 | 70 | $23,330 | $7,371 | 31.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $20,622 | $6,897 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $15,329 | $6,103 | 39.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 43 | 43 | $16,932 | $5,957 | 35.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 51 | 51 | $20,085 | $5,058 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 29 | $8,750 | $4,137 | 47.3% |
About Dr. John Khoury, M.D
Dr. John Khoury, M.D is a Sleep Medicine healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255549713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Khoury, M.D has received a total of $782,771 in payments from pharmaceutical and medical device companies, with $100,292 received in 2024. These payments were reported across 1,497 transactions from 68 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($533,219).
As a Medicare-enrolled provider, Khoury has provided services to 3,189 Medicare beneficiaries, totaling 3,836 services with total Medicare billing of $378,425. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Neurology
- Location Abington, PA
- Active Since 05/18/2007
- Last Updated 01/18/2021
- Taxonomy Code 2084S0012X
- Entity Type Individual
- NPI Number 1255549713
Products in Payments
- XYWAV (Drug) $311,219
- SUNOSI (Drug) $158,884
- BELSOMRA (Drug) $137,878
- Xyrem (Drug) $39,611
- Sunosi (Drug) $35,021
- Dayvigo (Drug) $32,920
- XYREM (Drug) $20,624
- LUMRYZ (Drug) $13,645
- SOLIRIS (Biological) $2,472
- QUVIVIQ (Drug) $1,755
- ULTOMIRIS (Biological) $1,369
- WAKIX (Drug) $990.08
- Aimovig (Biological) $746.21
- TROKENDI XR (Drug) $569.89
- Briviact (Drug) $444.39
- Wakix (Drug) $433.53
- QULIPTA (Drug) $403.76
- APTIOM (Drug) $325.57
- VYVGART HYTRULO (Drug) $289.10
- Neupro (Drug) $282.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.